The New York Times’s (NYSE:NYT) Q2 CY2026 Sales Top Estimates But Stock Drops
The New York Times (NYSE: NYT) reported Q2 CY2026 revenue of $762.5 million, up 11.2% year on year and 1.4% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $0.69, 3.6% above consensus. Analysts expect revenue growth of 7.3% over the next 12 months. Shares fell 7.7% to $69.80 after results.
How this was made

The 30-second read
Why it matters
NYT’s quarter beat on both revenue and adjusted EPS, but the stock dropped 7.7% to $69.80 immediately after results. The text attributes investor disappointment to weaker forward revenue growth expectations (7.3% over the next 12 months) and notes monetization has fallen because subscriber growth exceeds revenue growth.
Market read
A concrete earnings beat with an immediate negative price reaction, plus a specific forward revenue growth expectation, creates a tradable setup for near-term positioning around expectations and monetization.
What to watch
Subscriber growth outpacing revenue growth suggests monetization pressure; traders may focus on whether management can re-accelerate revenue per subscriber rather than headline subscriber counts.
Background
The article frames NYT’s Q2 CY2026 results versus revenue and EPS consensus, and discusses longer-term revenue growth and subscriber trends.
Ticker impact
NYT reported Q2 CY2026 revenue of $762.5M, up 11.2% YoY, and adjusted EPS of $0.69, both beating consensus, yet shares fell 7.7%.
Near-term volatility likely persists as the market digests the gap between the beat and the implied outlook.
The article provides the beat magnitude and the immediate selloff, plus a forward revenue growth expectation of 7.3% that is described as underwhelming, which can explain the negative reaction.
Market effects
Signals that media/subscription monetization and subscriber-to-revenue conversion remain key valuation drivers even when quarterly results beat.
Limited, as the catalyst is company-specific earnings performance.
Limited, no cross-border deal or regulatory action described.
Counterpoint
The beat plus stable operating margin (15.5%) could be a sign the business is executing, and the selloff may be more about valuation or expectations than deterioration.
Key entities
- companyThe New York Times
Reported Q2 CY2026 revenue and adjusted EPS that beat consensus, but shares fell sharply post-release.



